|1.||Haylock, Anna-Karin: 1 article (02/2016)|
|2.||Mortensen, Anja C: 1 article (02/2016)|
|3.||Nilvebrant, Johan: 1 article (02/2016)|
|4.||Tolmachev, Vladimir: 1 article (02/2016)|
|5.||Eriksson, Olof: 1 article (02/2016)|
|6.||Spiegelberg, Diana: 1 article (02/2016)|
|7.||Nestor, Marika V: 1 article (02/2016)|
|8.||Selvaraju, Ram K: 1 article (02/2016)|
|1.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/01/2016 - "Biodistribution and small-animal PET studies demonstrated that the recombinant Fab-dHLX construct AbD19384 is a promising tracer for imaging of CD44v6 antigen expression in vivo, with the future aim to be used for individualized diagnosis and early detection of squamous cell carcinomas in the head and neck region. "
08/01/1996 - "In the recurrent tumor, expression of immunohistochemical markers of malignancy, such as p53 protein and CD44v6 antigen were increased. "
07/01/1996 - "A bispecific F(ab')2 antibody conjugate (BAC) was constructed against the complement receptor CR3 of macrophages and variant CD44 (CD44v6) antigen of rat pancreatic adenocarcinoma cells to redirect macrophage-mediated tumor cytotoxicity. "
|1.||Complement Receptors (Complement Receptor)